महत्वपूर्ण लक्षणों के साथ न्यूरोलॉजिकली स्थिर क्रोनिक सबड्यूरल हेमेटोमा का उपचार

References

DOI: 10.1161/STROKEAHA.123.044129

• Patients with significant symptoms are typically associated with an initial hematoma thickness >10 mm or a midline shift >5 mm, and they are typically considered for surgical treatment.
• Surgical evacuation of symptomatic and larger cSDH is the standard of care; however, patient outcomes are variable, and rates of recurrence are high.
• A variety of surgical techniques are routinely used for the evacuation of cSDH.
• Current data supports MMAE as an adjunct to conventional surgical or nonsurgical management.
• Imaging end points are based on serial CT studies being performed between 3 and 6 months after enrollment to assess for adequate regression of the hematoma volume.
• Adequate regression has been defined as either a reduction to <10 mm in the greatest thickness or ≥50% reduction in volume.